title: Involvement of acidic fibroblast growth factor in spinal cord injury repair processes revealed by a proteomics approach.
abstract: Acidic fibroblast growth factor (aFGF; also known as FGF-1) is a potent neurotrophic factor that affects neuronal survival in the injured spinal cord. However, the pathological changes that occur with spinal cord injury (SCI) and the attribution to aFGF of a neuroprotective effect during SCI are still elusive. In this study, we demonstrated that rat SCI, when treated with aFGF, showed significant functional recovery as indicated by the Basso, Beattie, and Bresnahan locomotor rating scale and the combined behavior score (p < 0.01-0.001). Furthermore proteomics and bioinformatics approaches were adapted to investigate changes in the global protein profile of the damaged spinal cord tissue when experimental rats were treated either with or without aFGF at 24 h after injury. We found that 51 protein spots, resolvable by two-dimensional PAGE, had significant differential expression. Using hierarchical clustering analysis, these proteins were categorized into five major expression patterns. Noticeably proteins involved in the process of secondary injury, such as astrocyte activation (glial fibrillary acidic protein), inflammation (S100B), and scar formation (keratan sulfate proteoglycan lumican), which lead to the blocking of injured spinal cord regeneration, were down-regulated in the contusive spinal cord after treatment with aFGF. We propose that aFGF might initiate a series of biological processes to prevent or attenuate secondary injury and that this, in turn, leads to an improvement in functional recovery. Moreover the quantitative expression level of these proteins was verified by quantitative real time PCR. Furthermore we identified various potential neuroprotective protein factors that are induced by aFGF and may be involved in the spinal cord repair processes of SCI rats. Thus, our results could have a remarkable impact on clinical developments in the area of spinal cord injury therapy.
authors.affiliation: Institute of Biochemistry and Molecular Biology, School of Life Sciences, National Yang-Ming University, Taipei 11221, Taiwan.
authors.forename: Ming-Chu
authors.initials: MC
authors.lastname: Tsai
authors.forename: Li-Fen
authors.initials: LF
authors.lastname: Shen
authors.forename: Huai-Sheng
authors.initials: HS
authors.lastname: Kuo
authors.forename: Henrich
authors.initials: H
authors.lastname: Cheng
authors.forename: Kin-Fu
authors.initials: KF
authors.lastname: Chak
mesh_terms: D000818:Animals; D015153:Blotting, Western; D005260:Female; D016220:Fibroblast Growth Factor 1 / Q000494:pharmacology* / Q000502:physiology; D019922:GAP-43 Protein / Q000378:metabolism; D009416:Nerve Regeneration / Q000187:drug effects*; D014176:Protein Biosynthesis / Q000187:drug effects; D011499:Protein Processing, Post-Translational; D011506:Proteins / Q000378:metabolism; D040901:Proteomics; D051381:Rats; D017207:Rats, Sprague-Dawley; D013116:Spinal Cord / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D013119:Spinal Cord Injuries / Q000378:metabolism / Q000503:physiopathology*; D050777:Stathmin / Q000378:metabolism
chemical_list: D019922:GAP-43 Protein; D011506:Proteins; D050777:Stathmin; D016220:Fibroblast Growth Factor 1